Oxford Immunotec will perform T cell testing on participants receiving Valneva’s vaccine candidate
News
Gilead and Vir unite to find a ‘functional cure’ for hepatitis B
Companies will collaborate on a combination therapy study
Roche’s Tecentriq/Avastin combo improves survival in liver cancer
Updated analysis is from the Phase III IMbrave150 study
Diurnal seeks marketing authorisation for Chronocort in the UK
MHRA submission is based on same application filed with the EMA
Eli Lilly announces mid-stage trial success for donanemab in Alzheimer’s
Investigational antibody targets a modified form of beta amyloid called N3pG
Synairgen begins large-scale trial of inhaled COVID-19 treatment
First patient in global trial dosed in the UK
Biogen and Apple partner on cognitive health study
Study will evaluate the role of smart devices on monitoring cognitive health
ICR researchers identify potential new treatment for drug-resistant prostate cancer
CCS1477 has a novel mechanism of action compared to existing treatments
DHSC publishes ‘UK Rare Disease Framework’
Framework identifies four key priorities and five ‘underpinning themes’
UK government unveils ‘largest vaccination programme in British history’
Plan aims to rapidly scale-up COVID-19 vaccination programme
Boehringer Ingelheim announces partnership with Google
Partnership will aim to research and implement quantum computing in pharma R&D
EU OK for Roche’s oral flu treatment Xofluza
Oral treatment approved to treat uncomplicated influenza and for post-exposure prophylaxis
Sanofi to acquire Kymab for up to $1.45bn
Acquisition will add monoclonal antibody KY1005 to Sanofi’s pipeline
England to launch rapid asymptomatic COVID-19 testing this week
Testing will be aimed at people who cannot work from home during national lockdown
BREAKING NEWS: Moderna’s COVID-19 vaccine granted authorisation in UK
Third vaccine to receive approval from the UK’s MHRA
